Channel Medsystems Company
Channel Medystems is a clinical-stage medical technology engaged in the development of proprietary cryo-ablation delivery technologies to treat heavy menstrual bleeding. The company's cryothermic technology and the streamlined delivery system uses extreme cold to destroy tissues, as well as integrates cryothermic energy and the user controls into a self-contained and handheld device, enabling female patients to meet their needs without the need for anesthesia and in the comfort of their physician's office.
The company’s technology, Cerene® Cryotherapy, is a well-tolerated in-office endometrial ablation treatment that safely and effectively reduces heavy menstrual bleeding without general anesthesia and while preserving access to the uterine cavity for future diagnostic evaluations.
The company’s technology, Cerene® Cryotherapy, is a well-tolerated in-office endometrial ablation treatment that safely and effectively reduces heavy menstrual bleeding without general anesthesia and while preserving access to the uterine cavity for future diagnostic evaluations.
Industry:
Menstrual Health
Headquarters:
Berkeley, California, United States
Founded Date:
01-01-2009
Employees Number:
11-50
Funding Status:
Late Stage Venture
Investors Number:
9
Total Funding:
$52,887,000
Estimated Revenue:
$1M to $10M
Last Funding Date:
2017-08-23
Last Funding Type:
Series C
Register and Claim Ownership